Published June 30, 2022 | Version v1
Journal article Open

Recent improvements in mRNA and immunogenicity

  • 1. Faculty of Pharmacy, University of Tripoli

Description

Vaccines avoid many illnesses and save many lives every year. As a result of common vaccine use, the smallpox virus has entirely been eradicated and the occurrence of measles, polio and other childhood diseases have considerably been abridged around the world. Classical vaccine strategies, for instance inactivated pathogen, live attenuated and subunit vaccines, offer strong protection against diversity of hazardous diseases. In spite of this achievement, there remain chief obstacles to vaccine development against a diversity of infectious pathogens, part-icularly those better able to avoid the adaptive immune response. Furthermore, for most emer-ging virus vaccines, the main barrier is not the efficiency of usual approaches but the requirements for more rapid development and large-scale use. Nucleic acid therapeutics have appeared as hopeful option to classical vaccine approaches. 

Files

2022-2-2-1.pdf

Files (154.5 kB)

Name Size Download all
md5:7fc84e55039461cdb76503bbb8512669
154.5 kB Preview Download